#Granules India share nse
Explore tagged Tumblr posts
Text
AajKe2000: Here is WHY Market Guru Anil Singhvi suggests to BUY Granules India for bumper returns - Check price target here
AajKe2000: Here is WHY Market Guru Anil Singhvi suggests to BUY Granules India for bumper returns – Check price target here
In Zee Business special edition of AajKe2000 show, Managing Editor Anil Singhvi recommends to Buy Granules India shares as the National Pharmaceutical Pricing Authority (NPPA) allowed a 50 per cent price hike on Ibuprofen drug mentioning it a one-time hike as an exceptional measure. The authority has also allowed a 50 per cent price rise on Carbamazepine and Ranitidine drugs. See Zee Business…
View On WordPress
#business news#Carbamazepine#Granules India#Granules India API#Granules India latest news#Granules India news#Granules India owner#Granules India products#Granules India share bse#Granules India share nse#Granules India share price#Granules India share price bse#Granules India share price chart#Granules India share price dividend#Granules India share price history#Granules India share price nse#Granules India share price target#Granules India target price#Ibuprofen#National Pharmaceutical Pricing Authority#news#NPPA#Ranitidine#Zee Business
0 notes
Text
Celestial Biolabs Ltd Live Share Price, Celestial Biolabs Live Stoke Price
Celestial Biolabs Limited creates, fabricates, showcases, and disseminates home grown and feed supplement plans in India. The organization offers a scope of single and numerous home grown and ocean based definitions. Its home grown items incorporate syrups, for example, liver tonics, blood purifiers, and stomach related tonics, just as syrups to treat gynecological issues, hack and hypersensitive issues, and utilitarian or metabolic effectiveness; cases for joint torments, sexual issues, unfavorably susceptible dermatitis, the runs, diarrhea, bad tempered entrail condition, giardiasis, amoebiasis, sinusitis, upper respiratory plot contamination, fever, and cerebrovascular sickness; granules to control pressure; oil items for relief from discomfort and portability upgrade; and decency creams, just as different ayurvedic items.
The organization was in the past known as Celestial Technologies Limited and changed its name to Celestial Biolabs Limited in February 2004. Heavenly Biolabs Limited was consolidated in 1997 and is situated in Hyderabad, India.
Check Celestial Biolabs Ltd
Industry: Biotechnology
Sector: Healthcare
SYMBOL
BSE: CELESTIAL.BO
CELESTIAL.BO ₹2.02
Range: 2.02-2.02
week range:1.99-4.37
Volume: ₹124.00
Shares outstanding:22.59M
Market cap: ₹45.62M
NSE: CELESTIAL.NS
CELESTIAL.NS₹1.75
Range: 1.75-1.80
week range:1.75-4.35
Volume: ₹8.32K
Shares outstanding:22.59M
Market cap: ₹45.62M
0 notes
Text
How pharmacy application will help you to grow your pharma business while all other industries are facing big loss due to Coronavirus disease?
AS THE NEW CORONAVIRUS spreads death, illness, and catastrophe around the globe, virtually no economic sector has been saved from harm. However amid the disorder from the worldwide pandemic, one industry isn’t just surviving, it is benefitting liberally.
“Pharmaceutical organizations view Covid-19 as a once-in-a-blue-moon business opportunity,” said Gerald Posner, author of “Pharma: Greed, Lies, and the Poisoning of America.” The world needs pharmaceutical products, obviously. For the new coronavirus outbreak, specifically, we need vaccines and treatments and, in the U.S., tests. Many organizations are presently vying to make them.
“They’re all in that race,” said Posner, who described the potential payoffs for winning the race as tremendous. The worldwide emergency “will possibly be a blockbuster for the industry in terms of profits and sales,” he said, including that “the more awful the pandemic gets, the higher their inevitable profit.”
During the present crisis, pharmaceutical makers may have considerably more leeway than expected because of language industry lobbyists embedded into an $8.3 billion coronavirus spending package, passed last week, to amplify their profits from the pandemic.
Notwithstanding shares of Piramal Enterprises that fell around 0.3%, all the 9 other healthcare shares were trading more on Nifty Pharma, which was high around 0.78% at 8,200.
On Nifty Pharma, Cadila Healthcare was the highest gainer, rising 4.7%, trailed by 2% gain in Divi's Laboratories. Biocon increased by 1.68%, while Sun Pharma and Dr Reddy's were up 1%. Cipla Glenmark, and Aurobindo Pharma, Pharmaceuticals gained in the range of 0.2% to 0.8%.
Shares of Biocon, Dr Reddy's Labs, and Divi's Laboratories were moving towards their 52-week highs on NSE today.
Nifty Pharma index has gained 3.68% in one week, 2.7% in one month and 1.68% since the beginning of 2020.
On a similar note, BSE Healthcare traded at 14,194, rising 0.81%, with 20 of 30 scrips trading in the green. On the BSE sector list, Shilpa Medicare and IOL Chemical rose around 5% each, followed by 4-5% high in Marksans Pharma, Panacea Biotec, and Cadila. Albert David, Laurus Labs, and Granules India gained around 3% each.
BSE Healthcare index has gained 1.87% in one week, 1.80% in one month and 5.72% since the beginning of 2020.
The rise in the share price of healthcare stocks is on the back of the global trend. The spread of the novel coronavirus has driven worldwide investors to scramble for pharmaceutical stocks s of late, on back of a rise in demand for branded generics and generics prompting to over-pricing and shortages for drugs. All around, the number has moved to more than 95,000 affected and more than 3,200 fatalities.
How Online Pharma Application is Helping Pharma companies to deliver medicines quickly
Allowing consumers to be more accessible to the medicines
Consumers can easily order their prescribed medicines through mobile app and get it delivered right to their door
Educating and informing people about their health and safety concerns in corona situation
Through advanced technology used in the mobile app, pharmacies can ensure that your prescriptions are filled correctly and you get the right medicine
They can handle a larger number of prescriptions and deliver medicines with a higher efficiency rate
With a customized mobile healthcare solution, pharma companies can focus more on patient’s clinical needs instead of counting pills
Enable remote monitoring by health professionals of a patient's condition and adherence to treatment
If you’re a pharma company having an existing online medicine delivery app or want to develop an advance medicine delivery app that can help consumers in such crisis as coronavirus and increase your brand name as well as revenue, feel free to contact EMedStore – A leading pharma solution provider.
Be safe, and maintain hygiene!
0 notes
Link
Equity benchmark indices oscillated between gains and losses in the opening trade tracking sluggish Asian stocks, as US-China trade talks resume and the Federal Reserve is expected to deliver its first interest-rate cut in a decade. The Sensex is down 62 points at 37,820, while the Nifty dropped by 12 points to trade at 11,255 levels. The Nifty Auto is trading 2% lower at 7,008.80 levels led by Bajaj Auto, Eicher and Hero MotoCorp. The stock was under pressure after the GST Council on Saturday cut tax rates on electric vehicles from 12% to 5%, whereas for EV chargers, it was reduced from 18% to 5%. The new rates will be effective from August 1. Granules India stock gained 1% on the NSE. USFDA has completed an inspection at the company's Bonthapally facility located at Hyderabad with one 483 observation which is procedural. Shares of Vedanta dropped 1.5% after the company posted an 11.9%yoy fall in its Q1FY20 net profit at Rs1,351cr, down from Rs1,533cr. Meanwhile, the 10-year government bond yield fell nearly 8bps after FM Nirmala Sitharaman said a rate cut will help the economy and the government is reviewing a proposal to issue any sovereign debt overseas. The Volatility gauge, India VIX, was up 5.13% at 12.77. The most active stocks on the NSE are ICICI Bank, Indiabulls Housing and Yes Bank. Get more details here: Mcx Tips, Derivative-Free Trial, Stock tipsCall on:9977499927* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
0 notes
Text
CCL Products India Ltd Live Share Price, CCL Products Live Stock Price
CCL Products (India) Limited delivers, exchanges, and appropriates moment espresso and espresso related items basically in India. It offers splash dried espresso powder and granules, freeze dried espresso, freeze concentrate fluid espresso, meal and ground espresso, simmered espresso beans, and premix espresso.
The organization gives its items in different packs, for example, containers, jars, pockets/sachets, large sacks, drums, and mass boxes under the Continental Speciale, Continental XTRA, and Continental Black Edition brand names. It likewise trades its items to around 90 nations. The organization was consolidated in 1961 and is situated in Hyderabad, India.
Check CCL Products India Ltd
Industry: Packaged Foods
Sector: Consumer Defensive
SYMBOL
BSE: CCL.BO
CCL.BO ₹246.45
Range:244.80-248.65
week range:137.25-293.80
Volume: ₹2.38K
Shares outstanding:133.03M
Market cap: ₹32.78B
NSE: CCL.NS
CCL.NS ₹247.55
Range:242.60-248.15
week range:137.00-292.20
Volume: ₹6.95K
Shares outstanding:133.03M
Market cap: ₹32.95B
0 notes